These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Corticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel Gβγ signaling pathway. Stern CM; Luoma JI; Meitzen J; Mermelstein PG PLoS One; 2011 Mar; 6(3):e18114. PubMed ID: 21448293 [TBL] [Abstract][Full Text] [Related]
25. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats. Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861 [TBL] [Abstract][Full Text] [Related]
26. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze. Silva MSCF; Souza TMO; Pereira BA; Ribeiro DA; Céspedes IC; Bittencourt JC; Viana MB Behav Brain Res; 2017 Jun; 329():41-50. PubMed ID: 28435125 [TBL] [Abstract][Full Text] [Related]
27. Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin. Parham KL; Zervou S; Karteris E; Catalano RD; Old RW; Hillhouse EW Endocrinology; 2004 Aug; 145(8):3971-83. PubMed ID: 15142984 [TBL] [Abstract][Full Text] [Related]
28. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779 [TBL] [Abstract][Full Text] [Related]
30. Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10. Sashinami H; Kageyama K; Suda T; Nakane A Endocrinology; 2005 Nov; 146(11):5003-11. PubMed ID: 16081642 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells. Kageyama K; Hanada K; Nigawara T; Furukawa K; Terui K; Ogura E; Motomura S; Suda T Peptides; 2007 May; 28(5):1059-67. PubMed ID: 17346851 [TBL] [Abstract][Full Text] [Related]
32. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells. Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045 [TBL] [Abstract][Full Text] [Related]
33. Formononetin induces apoptosis in PC-3 prostate cancer cells through enhancing the Bax/Bcl-2 ratios and regulating the p38/Akt pathway. Zhang X; Bi L; Ye Y; Chen J Nutr Cancer; 2014; 66(4):656-61. PubMed ID: 24666255 [TBL] [Abstract][Full Text] [Related]
34. Activation of corticotropin-releasing factor 2 receptor inhibits Purkinje neuron P-type calcium currents via G(o)alpha-dependent PKC epsilon pathway. Tao J; Zhang Y; Huang H; Jiang X Cell Signal; 2009 Sep; 21(9):1436-43. PubMed ID: 19439178 [TBL] [Abstract][Full Text] [Related]
35. Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2. Emeto TI; Moxon JV; Biros E; Rush CM; Clancy P; Woodward L; Moran CS; Jose RJ; Nguyen T; Walker PJ; Golledge J Clin Sci (Lond); 2014 Apr; 126(7):517-27. PubMed ID: 24107226 [TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats. Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941 [TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing hormone and urocortin promote phagocytosis of rat macrophages through convergent but distinct pathways. Wang WC; Zhang XZ; Liu DW; Qiu J; Wang XH; Zhou JH Life Sci; 2015 Feb; 122():100-7. PubMed ID: 25534437 [TBL] [Abstract][Full Text] [Related]
38. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Chen A; Blount A; Vaughan J; Brar B; Vale W Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736 [TBL] [Abstract][Full Text] [Related]
39. Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2. Zhu C; Sun Z; Li C; Guo R; Li L; Jin L; Wan R; Li S Cell Signal; 2014 May; 26(5):1125-34. PubMed ID: 24518041 [TBL] [Abstract][Full Text] [Related]
40. The effects of neuropeptide urocortin 2 on the spontaneous discharge and glutamatergic neurotransmission of striatum neurons. Liu C; Liu X; Song F; Li J; Zhang X; Yang J Neuropeptides; 2015 Apr; 50():17-21. PubMed ID: 25837973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]